Comprehensive, Evidence-Based Update on Disease-Modifying Therapies (DMTs) and Symptom Management in Multiple Sclerosis: A Clinical Overview for Physicians

I. Disease-Modifying Therapy (DMT) Indications & Goals Multiple sclerosis (MS) remains an immune-mediated demyelinating disease of the central nervous system (CNS), characterized by neuroinflammation, axonal transection, and progressive neurodegeneration. While…

Continue ReadingComprehensive, Evidence-Based Update on Disease-Modifying Therapies (DMTs) and Symptom Management in Multiple Sclerosis: A Clinical Overview for Physicians

Dimethyl Fumarate: A Comprehensive Review for Pharmacists in the Management of Relapsing Multiple Sclerosis (MS)

1. Overview and Indications Dimethyl fumarate (DMF), marketed under the brand name Tecfidera, is an FDA-approved disease-modifying therapy (DMT) for adults with relapsing forms of multiple sclerosis (MS), including clinically…

Continue ReadingDimethyl Fumarate: A Comprehensive Review for Pharmacists in the Management of Relapsing Multiple Sclerosis (MS)